Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02549937
Title A Multi-Center, Open-Label Study of Sulfatinib(HMPL-012) in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hutchison Medipharma Limited
Indications

Advanced Solid Tumor

Therapies

Surufatinib

Age Groups: adult
Covered Countries USA | ITA

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center Los Angeles California 91010 United States Details
Rocky Mountain Cancer Center Denver Colorado 80218 United States Details
SCRI at HealthONE Denver Colorado 80218 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Mount Sinai Hospital New York New York 10029 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10072 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
Mary Crowley Cancer Research Center Dallas Texas 75230 United States Details
Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Virginia Cancer Specialists, PC Fairfax Virginia 22031 United States Details
Fondazione IRCCS Istituto Nazionale dei Tumori Milano Italy Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field